Type 2 diabetes in adolescents and young adults
Open accessAbstract
The prevalence of type 2 diabetes in adolescents and young adults is dramatically increasing. Similar to older-onset type 2 diabetes, the major predisposing risk factors are obesity, family history, and sedentary lifestyle. Onset of diabetes at a younger age (defined here as up to age 40 years) is associated with longer disease exposure and increased risk for chronic complications. Young-onset type 2 diabetes also affects more individuals of working age, accentuating the adverse societal effects of the disease. Furthermore, evidence is accumulating that young-onset type 2 diabetes has a more aggressive disease phenotype, leading to premature development of complications, with adverse effects on quality of life and unfavourable effects on long-term outcomes, raising the possibility of a future public health catastrophe. In this Review, we describe the epidemiology and existing knowledge regarding pathophysiology, risk factors, complications, and management of type 2 diabetes in adolescents and young adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
20 of 80 cited sources checked · 1 supported · 0 flagged · accuracy not yet measured
- Study design and conductcitation
Apparent ethnic differences based on regional prevalence data are limited because diagnostic criteria and data collection methods are not always consistent.
“However, apparent ethnic differences based on regional variations in prevalence (table 1), have the limitation that the diagnostic criteria and methods of data collection are not always consistent [15][16][17] .”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [15] Kim, 2010, The clinical characteristics of the newly diagnosed early onset (<40 years old) diabetes in outpatients' clinic, Korean Diabetes J source
The Discussion reports regional differences in early-onset diabetes prevalence and says differing patient recruitment and data-collection methods could explain discrepancies between studies. It also shows that studies used different age cutoffs, but does not establish that diabetes diagnostic criteria were inconsistent or specifically assess ethnic differences. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [16] Chuang, 2006, Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia, Diabetes Res Clin Pract source
- cites [17] Jimenez-Corona, 2010, Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006, Salud Publica Mex source
- Premisecitation
A comparable decline in second-phase insulin secretion would take more than a decade to appear in most patients whose type 2 diabetes presents in middle or later life.
“Such a decrease in second phase insulin secretion would take more than a decade to emerge in most T2DM patients presenting in middle or later life [21][22] .”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [21] Bagust, 2003, Deteriorating beta–cell function in type 2 diabetes: a long–term model, QJM source
- cites [22] Kahn, 2003, The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes, Diabetologia source
The intravenous-testing section (p. 8) reports reduced second-phase insulin responses in people at high risk of type 2 diabetes, supporting the claim that this response can decline. It does not say that a comparable decline takes more than a decade in most patients whose diabetes presents in middle or later life; the longitudinal study discussed on p. 7 followed a different, high-risk population for an average of five years. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Intrauterine environment changes influence obesity and type 2 diabetes development more strongly in adolescents and young adults than in later life.
“Changes in the intrauterine environment influence development of obesity and type 2 diabetes in adolescents and young adults more strongly than in later life.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [31] Reinehr, 2016, Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines, J Pediatr source
- cites [32] Vrachnis, 2012, Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring, Exp Diabetes Res source
Section 3 (page unavailable) says exposure to a diabetic intrauterine environment contributes to obesity and diabetes in offspring. Section 2.2 reports higher diabetes incidence among exposed offspring in all age groups, but neither passage says the effect is stronger in adolescents and young adults than later in life. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Maternal undernutrition and overnutrition are linked to a greater increased risk of obesity and type 2 diabetes in adolescence and early adulthood than later in life.
“Maternal undernutrition and overnutrition are associated with a greater increased risk of obesity and type 2 diabetes in adolescence and early adulthood than in later life ,31,32 .”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [31] Reinehr, 2016, Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines, J Pediatr source
- cites [32] Vrachnis, 2012, Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring, Exp Diabetes Res source
Section 3 (page unavailable) links exposure to a diabetic intrauterine environment with greater offspring risk of obesity and diabetes. It does not address maternal undernutrition or show that the risk is greater in adolescence and early adulthood than later in life. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Insulin resistance is directly related to a higher percentage of fat in muscle and liver across all age groups.
“However, IR is directly related to an increased percentage of fat in muscle and liver in all age groups 6 ,”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [6] Mayer-Davis, 2017, Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012, N Engl J Med source
The Discussion (page unavailable) says that changes in obesity prevalence among youths may contribute to changes in insulin resistance. It does not address fat percentages in muscle or liver, a direct relationship with insulin resistance, or all age groups; searches for muscle and liver fat found no such passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Higher circulating levels of these pro-inflammatory markers are reported in adolescents with type 2 diabetes.
“Increased circulating concentrations of these pro-inflammatory markers are reported in adolescents with T2DM 30 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [30] Lumeng, 2011, Inflammatory links between obesity and metabolic disease, J Clin Invest source
The Antiinflammatory therapies for metabolic disease section (page unavailable) reports that treatment in type 2 diabetes decreases systemic inflammatory markers, supporting a general link between these markers and the disease. The Pancreatic islets section discusses adolescents only in relation to adipose tissue, not circulating marker concentrations in adolescents with type 2 diabetes. That population-specific finding is not supported by our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Premisecitation
Rapid weight gain in the first four months of life is associated with a higher risk of overweight at age seven.
“Thus, in a large prospective study, rapid weight gain during the first 4 months of life was associated with an increased risk of overweight at age 7 years 34 ,”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [34] Jiang, 2013, Early life factors and type 2 diabetes mellitus, J Diabetes Res source
The 'Catch-Up Growth' section links early growth to increased fat gain, and the 'Lactation—Overnutrition' section links neonatal overfeeding to later overweight in animal models. Neither section reports a large prospective study associating weight gain in the first four months of human life with overweight at age seven; the age-seven finding concerns insulin sensitivity, not overweight. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Widespread use of corn-derived fructose syrup as a sweetener in fizzy drinks substantially affects adiposity, insulin resistance, hyperglycaemia and other cardiometabolic risk factors in young people.
“The widespread use of corn derived fructose syrup as a sweetening agent in 'fizzy' drinks has a substantial impact on development of adiposity, IR, hyperglycaemia and other cardio-metabolic risk factors in the young 42,43 .”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [42] Gow, 2016, The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth, Nutrients source
Section 5, “Glycemic Index of the Diet” (page unavailable), reports that lower-GI diets can improve body weight and insulin resistance in children, supporting a general link between diet and some of the named risk factors. It does not establish that corn-derived fructose syrup in fizzy drinks is widely used or has a substantial effect on those outcomes in young people. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [43] Bray, 2004, Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity, Am J Clin Nutr source
- Premisecitation
Current funding systems are predicted to be unable to accommodate the growing demands for expensive long-term care caused by disease complications.
“including predictions that current funding systems will not be able to accommodate the growing demands for expensive longterm care incurred by the disease complications 3,147,150,151 .”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [3] 2016, Standards of medical care in diabetes—2016 abridged for primary care providers, Clin Diabetes source
The Older Adults section discusses diabetes complications and care in nursing homes and skilled nursing facilities, but it does not address the cost of that care. Searches for funding capacity and the economic burden of long-term care found no prediction that current funding systems will be unable to meet growing demand. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [150]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Early onset obesity and T2DM have been identified as particular threats to healthcare service capacity in Europe and North America.
“Early onset obesity and T2DM have also been identified as particular threats to the capacity of healthcare services across Europe and North America”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [3] 2016, Standards of medical care in diabetes—2016 abridged for primary care providers, Clin Diabetes source
In “Strategies for Improving Care > Diabetes Care Concepts” (page not provided), the paper says type 2 diabetes is increasing in children and young adults and calls for better coordination between clinical teams. It does not identify early-onset obesity and type 2 diabetes as particular threats to healthcare service capacity in Europe or North America. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [150]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisenone given
The worldwide frequency of type 2 diabetes among adolescents and young adults has risen sharply.
“The global prevalence of type 2 diabetes mellitus (T2DM) in adolescents and young adults is dramatically increasing.”
Quote in the paperNot a substantial claim - Premisecitation
A case-control study found that obese adolescents with type 2 diabetes for about 1.5 years had roughly 75% lower first-phase and 50% lower second-phase insulin secretion than obese non-diabetic peers.
“A case-control study of African-American and white Europids found that obese adolescents with T2DM for about 1.5 years have about a 75% decrease of first phase and a 50% decrease of second phase insulin secretion compared with obese non diabetic peers 20 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Taha, 2006, Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance, J Pediatr Endocrinol Metab source
- Premisecitation
Emerging evidence indicates that beta-cell function loss is accelerated in young-onset type 2 diabetes.
“Emerging evidence suggests that loss of beta cell function is accelerated in T2DMY.”
Quote in the paperSubstantial claim - Premisecitation
Type 2 diabetes is being diagnosed more often in children, adolescents and younger adults.
“T2DM is increasingly diagnosed in children, adolescents and younger adults.”
Quote in the paperSubstantial claim - Premisecitation
People born in the USA in 2000 have an estimated risk of diabetes by age 40 of about 2.5% for men and 5% for women.
“Individuals born in the USA in the year 2000 have a risk for diabetes by age 40 years of approximately 2•5% for men and 5% for women.,These estimates are doubled for Hispanic and black persons suggesting that certain ethnic groups are disproportionately affected 14 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Narayan, 2003, Lifetime risk for diabetes mellitus in the United States, JAMA source
- Premisecitation
In the UK, type 2 diabetes prevalence is higher in people of South Asian, African and African-Caribbean origin than in white European populations.
“In the UK, a higher prevalence is reported in people of South Asian, African and African-Caribbean origin compared with white European populations 13 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Haines, 2007, Rising incidence of type 2 diabetes in children in the UK, Diabetes Care source
- Premisecitation
A UK study found a significant rise over 20 years in the proportion of people diagnosed with type 2 diabetes at age 40 or younger.
“A study of the age specific incidence of T2DM in the UK reported a significant increase in the proportion of people aged ≤40 years at diagnosis (Figure 2) 12 over a 20 year period.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Holden, 2013, The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010, Diabetes Obes Metab source
- Premisecitation
The standardised incidence ratio of newly diagnosed type 2 diabetes under age 40 in the UK rose from 217 per 100,000 in 1996-2000 to 598 per 100,000 in 2006-2010.
“The standardized incidence ratio (per 100,000 population) of newly diagnosed T2DM aged <40 years increased from 217 in 1996-2000 to 598 in 2006-2010.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Holden, 2013, The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010, Diabetes Obes Metab source
- Interpretationcitation
Type 2 diabetes in young people may have a faster and more disruptive course than later-onset type 2 diabetes, causing early illness and poor quality of life.
“In addition, T2DMY may have a more rapid and disruptive natural history than T2DM presenting later in life, leading to early morbidity and poor quality of life 2 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Copeland, 2013, Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents, Pediatrics source
- Premisenone given
Obesity, family history and sedentary lifestyle are the main predisposing risk factors for type 2 diabetes in young people.
“As with older onset type 2 diabetes, the major predisposing risk factors are obesity, family history and sedentary lifestyle.”
Quote in the paperSubstantial claim - Premisecitation
The speed of onset, severity and interplay of reduced insulin sensitivity and defective insulin secretion in young-onset type 2 diabetes may differ from older presentations.
“However, the speed of onset, severity and interplay of decreased insulin sensitivity and defective insulin secretion during the development of T2DMY may differ from older presentations of T2DM 18 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Gungor, 2005, Youth type 2 diabetes: insulin resistance, β-cell failure, or both?, Diabetes Care source
- Premisecitation
The second phase of nutrient-induced insulin secretion may be compromised earlier in the disease process in younger people with type 2 diabetes.
“However, the second phase of nutrient-induced insulin secretion may be compromised earlier in the pathogenic process in younger individuals with T2DM 18,19-.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
A Taiwanese screening programme in children aged 6 to 18 years found a type 2 diabetes incidence of 6.5 per 100,000 versus 1.5 per 100,000 for type 1 diabetes.
“A nationwide screening programme of diabetes among children aged 6 to 18 years, in Taiwan between 1992 and 1999, found an incidence of newly diagnosed T2DM of 6•5 per 100,000 compared with 1.5 per 100,000 for T1DM 7 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Pinhas-Hamiel, 2005, The global spread of type 2 diabetes mellitus in children and adolescents, J Pediatr source
- Premisenone given
The mechanisms that lead to type 2 diabetes in young people are similar to those in older adults with type 2 diabetes.
“The mechanisms leading to development of T2DMY are similar to those in T2DM amongst older adults.”
Quote in the paperNot a substantial claim - Premisecitation
Physical inactivity among youth is associated with a higher risk of metabolic syndrome, insulin resistance and type 2 diabetes.
“Physical inactivity amongst youth is associated with increased risk of metabolic syndrome , insulin resistance and type 2 diabetes.[50][51] .”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The frequency and severity of complications in T2DMY may limit the ability to work.
“The frequency and severity of complications with T2DMY may limit capacity to work”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In an RCT of 82 youth with type 2 diabetes, mean HbA1c was significantly lower with metformin than placebo (7.5% vs 8.6%) at 4 months.
“The mean HbA1c significantly lower in the metformin group compared with the placebo (7.5% vs. 8.6%, respectively)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jones et al (2002) source
- Study design and conductcitation
Methodological deficiencies and lack of reliable baseline data make it difficult to quantify secular changes in leisure-time activity among adolescents and younger adults.
“However, owing to methodological deficiencies and lack of reliable baseline data, it is difficult to quantify the secular changes in leisure time activity in adolescents and younger adults 45 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Mayer-Davis, 2006, Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study, J Am Diet Assoc source
- Interpretationreasoning
Young-onset type 2 diabetes may have a more aggressive course with faster beta-cell function loss than type 2 diabetes presenting later in life.
“The reasons for this rapid failure of both phases of nutrient-stimulated insulin secretion are unclear but suggest that T2DMY may have more aggressive course with faster loss of beta cell function than T2DM presenting later in life.”
Quote in the paperSubstantial claim - Premisecitation
Large database analyses confirm a strong inverse relationship between BMI and age at type 2 diabetes diagnosis.
“and analyses of large databases have confirmed a strong inverse association between BMI and age at diagnosis of T2DM 27 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Hillier, 2001, Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset, Diabetes Care source
- Premisecitation
Post-partum undernutrition raises the risk of obesity and type 2 diabetes in young adults.
“while post-partum under nutrition increased the risk of obesity and type 2 diabetes in young adults 35 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Stettler, 2002, Infant weight gain and childhood overweight status in a multicenter, cohort study, Pediatrics source
- Premisecitation
In an RCT of 699 youth with type 2 diabetes, metformin plus rosiglitazone was significantly superior to metformin alone for glycaemic outcomes at 45 months.
“Metformin plus Rosiglitazone significantly superior to Metformin alone.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites TODAY Study Group (2012)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In later-life type 2 diabetes, insulin resistance severity is often greater in those with a history of long-standing severe obesity, especially with excess visceral fat.
“When T2DM presents in later life the severity of IR is often greater amongst those with a history of protracted and severe obesity, particularly with excess visceral adiposity 28 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Kahn, 2006, Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature source
- Premisenone given
Physical inactivity is associated with a higher risk of obesity.
“Physical inactivity is associated with increased risk of obesity.”
Quote in the paperNot a substantial claim - Premisecitation
Bariatric surgery in young people with type 2 diabetes yields significant improvements in weight and glycaemic markers, similar to older adults.
“Data in youth with type 2 diabetes are limited but nevertheless encouraging with significant improvements in weight and glycaemic indicators as seen in older adults (ref).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites ref
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a retrospective study of 80 youth with type 2 diabetes, 54% achieved HbA1c below 7% with lifestyle monotherapy at 12 months.
“54% achieved HbA1c < 7%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wittmeier et al (2013)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Accelerated beta-cell decline appears to contribute importantly to the development of type 2 diabetes in early life.
“Thus, accelerated decline of beta cell function appears to make an important contribution to the development of T2DM in early life.”
Quote in the paperSubstantial claim - Premisecitation
In the CARDIA study of 18-30 year olds, physical inactivity was strongly associated with risk of type 2 diabetes, hypertension and metabolic syndrome.
“Similarly, in the CARDIA study of 18 to 30 year olds, there was a strong association between physical inactivity and risk of type 2 diabetes , hypertension and metabolic syndrome 51 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Riddoch, 2004, Physical activity levels and patterns of 9- and 15-yr-old European children, Med Sci Sports Exerc source
- Premisecitation
Bariatric surgery is a viable treatment option for people with type 2 diabetes.
“This has emerged as a viable treatment option in individuals with T2DM 144”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [144]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Obesity prevalence is much higher in children, adolescents and young adults with type 2 diabetes than in older adults, for example over 80% versus 56% in one study.
“The prevalence of obesity among children, adolescents and young adults with T2DM is much greater than in older adults (eg.>80% versus 56% in a recent study 26 )”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Wilmot, 2014, Early onset type 2 diabetes: risk factors, clinical impact and management, Ther Adv Chronic Dis source
- Premisecitation
In a cross-sectional study of 7481 South/Southeast Asian subjects with young-onset type 2 diabetes, only 27% achieved HbA1c below 7%.
“Only 27% of subjects achieved a HbA1c <7%”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yeung et al (2014) source
- Premisecitation
In the Bogulusa Heart Study of young adults aged 20-38, leisure-time physical activity was inversely related to insulin resistance risk factors.
“In the Bogulusa Heart Study of young adults aged 20-38 years, an inverse relationship was observed between leisure time physical activity and risk factors for insulin resistance 50 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Troiano, 2008, Physical activity in the United States measured by accelerometer, Med Sci Sports Exerc source
- Premisecitation
Type 2 diabetes before age 20 appears 1-2 years earlier in offspring exposed to hyperglycaemia in utero.
“Also, T2DM before age 20 years emerges 1-2 years earlier in offspring exposed to hyperglycaemia in utero 31 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] Reinehr, 2016, Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines, J Pediatr source
- Interpretationnone given
The T2DMY phenotype shows poor long-term response to oral glucose-lowering drugs.
“poor sustainability of responsiveness to oral glucose lowering therapies”
Quote in the paperSubstantial claim - Premisecitation
Younger patients with T2DMY prominently report reduced quality of life due to visual impairment, frequent healthcare appointments, and lifestyle constraints.
“reduced quality of life through visual impairment, frequency of healthcare appointments and lifestyle constraints are prominently cited by younger patients 18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Gungor, 2005, Youth type 2 diabetes: insulin resistance, β-cell failure, or both?, Diabetes Care source
- Interpretationreasoning
The natural history of T2DMY is not simply a faster, earlier version of later-onset T2DM; it has distinct features.
“While it is tempting to extrapolate the natural history of T2DMY as just an earlier and more rapid form of later-onset T2DM, there are distinctive differences.”
Quote in the paperSubstantial claim - Interpretationnone given
The T2DMY phenotype is characterised by greater obesity.
“greater obesity”
Quote in the paperNot a substantial claim - Interpretationnone given
The T2DMY phenotype shows early impairment in both phases of insulin secretion.
“early loss of both first and second phases of insulin secretion”
Quote in the paperSubstantial claim - Interpretationreasoning
The T2DMY phenotype frequently necessitates early introduction of insulin.
“frequently necessitating early introduction of insulin”
Quote in the paperSubstantial claim - Interpretationnone given
The T2DMY phenotype is characterised by often severe insulin resistance.
“alongside often severe insulin resistance”
Quote in the paperNot a substantial claim - Interpretationcitation
The economic and sociological consequences of T2DMY are likely to be greater than those of later-onset T2DM.
“the economic and sociological sequelae are likely to be greater than for later-onset T2DM 147”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Protracted depression requiring substantial ongoing psychological support is common in T2DMY.
“Protracted depression requiring substantial on-going psychological support is common with T2DMY 148”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- May combine two claims. 28
- Classified as probably not a substantial claim. 6
May combine two claims.
PremisecitationA 20-35% yearly decline in beta-cell function has been reported in 10-19 year olds, compared with about 7% loss in older people with type 2 diabetes.
“A 20-35 % decline in beta cell function annually in 10-19 year olds has been reported compared to the ~7% loss in older individuals with T2DM 23 .”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [23] 2013, Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY, Diabetes Care source
The Conclusions report a 20–35% annual decline in β-cell function in the TODAY treatment groups and cite an approximately 7% annual decline in an adult study. The Study design section says TODAY participants were 10–17 years old at randomization, so the cited paper does not establish the claim’s stated 10–19-year-old age range. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn US youth aged 10 to 19 years, type 2 diabetes prevalence rose by 30.5% between 2001 and 2009, reaching 0.48 per 1000.
“Prevalence estimates suggest a 30•5% increase in T2DM amongst US youth aged 10 to 19 years between 2001 and 2009, accounting for prevalence of 0•48 per 1000 in this age group 5 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [5] Dabelea, 2014, Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009, JAMA source
May combine two claims.
PremisecitationThe SEARCH study found an annual 7.1% rise in type 2 diabetes incidence among US 10-19 year olds, from 9 per 100,000 in 2002-2003 to 12.5 per 100,000 in 2011-2012, with significant relative increases in all ethnic groups compared with non-Hispanic Whites.
“Recent data from the SEARCH study showed an annual increase of 7.1% in the incidence of T2DM (9 cases per 100,000 in 2002 -2003 to 12.5 cases per 100,000 in 2011-2012) amongst 10-19 year olds in the USA with significant relative increases in all ethnic groups compared to non Hispanic Whites 6 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [6] Mayer-Davis, 2017, Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012, N Engl J Med source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationYounger people with type 2 diabetes can have up to three times more liver fat than BMI-matched non-diabetic controls and than middle-aged or older type 2 diabetes presentations.
“and younger people with T2DM can have much higher (up to 3 times) amounts of liver fat compared with BMI-matched non-diabetic controls and compared with presentations of T2DM in middle and later life 24,”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Bacha, 2013, Progressive deterioration of β-cell function in obese youth with type 2 diabetes, Pediatr Diabetes source
The Results section (‘Study subjects and fasting metabolic profile’; page unavailable) reports abdominal fat and hepatic insulin sensitivity, but not liver-fat amounts. Searches for liver fat, intrahepatic fat, and a threefold difference found no comparison with BMI-matched non-diabetic controls or older people with type 2 diabetes in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPhysical activity declines further in adolescents than in younger children, and only a small proportion meet recommended levels; surveys in Europe and North America indicate about 80% of 13-15 year olds do less than 60 minutes of moderate or vigorous exercise daily, with girls less active than boys.
“Physical activity declines further in adolescents compared with younger children and only a small proportion meet recommended levels, eg recent surveys in Europe and North America indicate that about 80% of 13-15 year-olds undertake moderate or vigorous exercise for less than 60 minutes per day, with girls being less active than boys [46][47][48][49] .”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [46] Dollman, 2005, Evidence for secular trends in children's physical activity behaviour, Br J Sports Med source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [47] Kautiainen, 2005, Use of information and communication technology and prevalence of overweight and obesity among adolescents, Int J Obes source
- cites [48] Hallal, 2012, Global physical activity levels: surveillance progress, pitfalls, and prospects, Lancet source
May combine two claims.
PremisecitationAmong youth, the main contributors are increasing intake of calorie-dense foods and sugar-rich drinks and decreasing physical activity.
“Increasing consumption of calorie dense foods, and sugar-rich drinks and decreased physical activity are the main contributors amongst youth 39 .”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] Steyn, 2004, Diet, nutrition and the prevention of type 2 diabetes, Public Health Nutr source
The Physical inactivity section identifies inactivity as a risk factor for type 2 diabetes, and Recommendations and policy implications advises a diet low in free sugars alongside regular activity. The paper notes younger onset of diabetes, but these passages do not establish that calorie-dense foods and sugar-rich drinks, together with inactivity, are the main contributors specifically among youth. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe SEARCH study found few differences in macronutrient or fibre intake between youths with type 1 versus type 2 diabetes, but those with type 2 diabetes consumed twice as many sweetened beverages.
“Indeed, the SEARCH study showed few differences in macronutrient or fibre intake between youths with T1DM versus T2DM, but those with T2DM consumed twice the amount of sweetened beverages 44 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [44] Hu, 2010, Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence, Physiol Behav source
The Prospective cohort studies sections discuss sweetened-beverage intake and diabetes risk, but do not report the SEARCH study’s comparison of youths with type 1 versus type 2 diabetes. Searches for SEARCH, macronutrient and fibre intake, and the claimed twofold beverage difference found no passage addressing that comparison. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe global overweight and obesity pandemic now affects 36.9% of men, 38% of women, 23.8% of boys and 22.6% of girls.
“The global pandemic of overweight and obesity now affects 36.9% of men,38% of women, 23.8% of boys and 22.6% of girls 37 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [37] Yessoufou, 2011, Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of “metabolic memory”, Exp Diabetes Res source
Section 8 says obesity prevalence is increasing worldwide and that the pandemic affects children and adults. It does not give the claimed percentages for men, women, boys, or girls; searches for those figures and for global prevalence by sex and age found no such estimates in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationObesity is clearly a driver of the rise in young-onset type 2 diabetes, and lifestyle changes explain much of the increased obesity and type 2 diabetes prevalence in pre-adult and early adult life.
“Although the causes of obesity in children and adolescents are complex, obesity is clearly a driver for the upsurge in T2DMY and changes in lifestyle account for much of the increased prevalence of obesity and T2DM in pre-and early-adult life 38 .”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [38] Ng, 2014, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet source
The Discussion (page not provided) says rising overweight and obesity can drive up diabetes, and the Results report increasing obesity at younger ages. It does not establish a rise in young-onset type 2 diabetes specifically. The Discussion lists diet and physical activity among possible contributors to obesity but explicitly says the analysis does not measure their relative contributions, so it does not support the claim that lifestyle changes explain much of the increase. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationObese adolescents are reported to have chronically raised circulating free fatty acids, which reduce insulin sensitivity and may increase reactive oxygen species and impair insulin secretion.
“Compared with non-obese adolescents, obese adolescents are reported to have chronically increased circulating free fatty acids (FFA) which decrease insulin sensitivity and may contribute to increased reactive oxygen species and impair insulin secretion 29 .”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Cree-Green, 2013, Etiology of insulin resistance in youth with type 2 diabetes, Curr Diab Rep source
The “Mechanisms of Insulin Resistance in Children with T2DM” section reports increased FFA concentrations in obese children and describes how FFA can decrease insulin sensitivity, increase reactive oxygen species, and lead to defective insulin secretion. It does not establish that the FFA elevation is chronic or explicitly compare FFA concentrations in obese and non-obese adolescents. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationreasoningDeveloping diabetes at a younger age means longer exposure to the disease and a higher chance of chronic complications, affecting more people of working age and worsening societal effects.
“Onset of diabetes at a younger age is associated with longer disease exposure and increased risk for chronic complications affecting more individuals of working age and accentuating adverse societal impact of the disease.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAbout 8% of adults globally have diabetes, over 90% of them type 2, and this is projected to exceed 10% by 2040.
“The global prevalence of adults with diabetes is around 8% (>90% of whom have T2DM)with projections to increase to over 10% by 2040 1 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningEarlier onset results in longer lifetime hyperglycaemia exposure and therefore a greater likelihood of long-term complications.
“Earlier onset leads to longer lifetime exposure to hyperglycaemia and consequently greater propensity for long term complications.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe diabetes risk estimates for Hispanic and black persons are double those for the general population, indicating disproportionate ethnic impact.
“These estimates are doubled for Hispanic and black persons suggesting that certain ethnic groups are disproportionately affected 14 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Narayan, 2003, Lifetime risk for diabetes mellitus in the United States, JAMA source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe International Diabetes Federation estimated that in 2000 there were about 23 million young adults aged 20-39 with type 2 diabetes worldwide, representing 13% of 177 million adults with diabetes.
“The International Diabetes Federation estimated that in the year 2000 young adults aged 20-39 years with T2DM numbered approximately 23 million worldwide (13% of 177 million adults with diabetes 8 ).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] 2000
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningYoung diabetic groups show an aggressive phenotype with early complications, worse quality of life and poorer long-term outcomes, which could become a public health disaster.
“Evidence is also accumulating that young diabetic cohorts represent an aggressive phenotype leading to premature development of complications with an adverse impact on quality of life and unfavourably influencing long term outcomes, raising the possibility of a future public health catastrophe.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBy 2013 the estimated number of young adults aged 20-39 with type 2 diabetes had grown to 63 million, or 16% of 382 million adults with type 2 diabetes, with the largest increases in Africa, South East Asia and the Western Pacific.
“By 2013 this had increased to an estimated 63 million (16% of 382 million adults with T2DM [9][10][11] ), the biggest increases being in Africa, South East Asia and the Western Pacific regions (Figure 1).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [9] 2003
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10] 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11] 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenType 2 diabetes in young people affects more working-age individuals, which further increases its negative societal impact.
“Moreover,T2DMY affects more individuals of working age which further accentuates its adverse societal impact.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAlthough obesity is a prominent risk factor for young-onset type 2 diabetes, studies of insulin resistance, lipid metabolism and inflammation support the idea that hyperglycaemia in this age group depends more on beta-cell failure than in later-life type 2 diabetes.
“While obesity is clearly a prominent risk factor for T2DMY, studies focussed on IR, lipid metabolism and inflammation corroborate evidence in the previous section suggesting that the development of 'diabetic' hyperglycaemia in this age group appears to be more strongly dependent on beta-cell failure than T2DM in later life.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAlthough aerobic exercise can delay or prevent type 2 diabetes in older adults, the expected metabolic benefits from aerobic activity are comparatively smaller in those with young-onset type 2 diabetes.
“Although aerobic exercise can delay or prevent the development of type 2 diabetes in older adults, the expected metabolic benefits derived from aerobic activity are comparatively less in those with T2DMY 52 .”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Gustat, 2002, Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study, J Clin Epidemiol source
May combine two claims.
PremisecitationBariatric surgery is safe and effective in adolescents with obesity.
“there is now evidence that it is safe and effective in obese adolescents [145][146] .”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [145]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [146]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationObservational studies in adolescents of different ethnic groups confirm early beta-cell deterioration in young-onset type 2 diabetes, closely linked to insulin resistance severity in African-American adolescents but less so in white Europids and South Asians.
“Separate observational studies in adolescents of different ethnic groups have similarly confirmed the early deterioration of beta-cell function with T2DMY: this was closely associated with the severity of insulin resistance (IR) in African-American adolescents but less so in white Europids and South Asians 25,26 .”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [25] Mohan, 2013, Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians, Diabetes Technol Ther source
- cites [26] Wilmot, 2014, Early onset type 2 diabetes: risk factors, clinical impact and management, Ther Adv Chronic Dis source
May combine two claims.
PremisecitationRegular sweetened beverage consumption raises energy intake by about 10%, while larger portions, fast food access and snack advertising increase adiposity in children, adolescents and young adults.
“Regular consumption of sweetened beverages increases energy consumption by about 10%, while increased portion sizes, access to fast foods and targeted advertising of snacks increase adiposity in children, adolescents and young adults 40,41 .”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationEvidence on bariatric surgery in young people with type 2 diabetes is limited but encouraging.
“Data in youth with type 2 diabetes are limited but nevertheless encouraging with significant improvements in weight and glycaemic indicators as seen in older adults (ref).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites ref
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductcitationIn adolescents with type 2 diabetes, the relationship between obesity degree and insulin resistance extent has not been consistent, and data are insufficient to determine the role of visceral adiposity in this age group.
“In contrast, a relationship between the degree of obesity and the extent of IR has not been a consistent finding in studies of adolescents with T2DM, and there are insufficient data to determine the involvement of visceral adiposity in this age group 19 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Druet, 2006, Characterization of insulin secretion and resistance in type 2 diabetes of adolescents, J Clin Endocrinol Metab source
May combine two claims.
PremisecitationBetter transportation, television viewing and video games all contribute to sedentary behaviours.
“Nevertheless, better transportation, television viewing and video games all contribute to sedentary behaviours 45 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Mayer-Davis, 2006, Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study, J Am Diet Assoc source
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe T2DMY phenotype is characterised by a stronger family history.
“The T2DMY phenotype has a stronger family history”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenThe T2DMY phenotype shows early development and fast worsening of microvascular and macrovascular complications.
“early onset and rapid progression of micro-and macrovascular complications”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe continued rise of obesity and T2DM in young adults affects family members, friends, work colleagues, communities, and the prosperity of high-prevalence localities.
“The continued escalation of obesity and T2DM in young adults also impinges on the lives of other family members, friends, work colleagues, communities and the prosperity of localities where prevalence is particularly high 147,149 .”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [147]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [149]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
The cited studies' findings can be generalised to the broader population of adolescents and young adults with type 2 diabetes.
“Increasing numbers of children, adolescents and young adults with T2DM have been reported across most regions of the world.”
The authors state this as an assumption.
The age cutoff of 40 years defines a biologically and clinically meaningful group for the purposes of this review.
“For this review we have defined T2DMY as onset of type 2 diabetes ( ADA and WHO criteria 3,4 ) in adolescents and young adults up to age 40 years excluding secondary diabetes (drug-or chemicalinduced, exocrine pancreas disease, genetic defects), MODY, gestational diabetes and rare forms of diabetes.”
The paper relies on this without support.
Pregnancy is not uncommon in this age group with T2DMY.
“Pregnancy is not an uncommon occurrence in this age group”
The paper relies on this without support.
T2DMY can adversely affect maternal and foetal outcomes.
“the presence of T2DMY can adversely affect maternal and foetal outcomes ( Add reference).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Reported annual incidence growth does not match the endpoints
MinorThe incidence rises from 9 to 12.5 cases per 100,000 over approximately nine years, equivalent to about 3.7% compound growth per year, not 7.1%. A sustained 7.1% annual increase would produce about 16.7 cases per 100,000.
“an annual increase of 7.1% in the incidence of T2DM”
“(9 cases per 100,000 in 2002 -2003 to 12.5 cases per 100,000 in 2011-2012)”
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952 · see citing works
Physical Activity in the United States Measured by Accelerometer
TROIANO, R. P., BERRIGAN, D., DODD, K. W., MÂSSE, L. C., TILERT, T., & MCDOWELL, M. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31815a51b3 · Cited by 7,638 · see citing works
Global physical activity levels: surveillance progress, pitfalls, and prospects
Hallal, P. C., Andersen, L. B., Bull, F. C., Guthold, R., Haskell, W., & Ekelund, U. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60646-1 · Cited by 5,711 · see citing works
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · see citing works
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888 · see citing works
Childhood obesity: public-health crisis, common sense cure
Ebbeling, C. B., Pawlak, D. B., & Ludwig, D. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09678-2 · Cited by 2,980 · see citing works
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630 · see citing works
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · see citing works
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · see citing works
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
Bray, G. A., Nielsen, S. J., & Popkin, B. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.537 · Cited by 1,990 · see citing works
Unwin, N. C. (2006) · Cited by 1,661 · see citing works
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515 · see citing works
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476 · see citing works
Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412 · see citing works
Changes in physical activity patterns in the United States, by sex and cross-sectional age
CASPERSEN, C. J., PEREIRA, M. A., & CURRAN, K. M. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009000-00013 · Cited by 1,145 · see citing works
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
TODAY Study Group (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109333 · Cited by 978 · see citing works
Standards of Medical Care in Diabetes—2017 Abridged for Primary Care Providers
American Diabetes Association (2017) · Clinical Diabetes · doi:10.2337/cd16-0067 · Cited by 977 · see citing works
Neighborhoods, obesity, and diabetes—a randomized social experiment.
Ludwig, J., Sanbonmatsu, L., Gennetian, L., Adam, E., Duncan, G. J., Katz, L. F., Kessler, R. C., Kling, J. R., Lindau, S. T., Whitaker, R. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1103216 · Cited by 964 · see citing works
Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence
Hu, F. B., & Malik, V. S. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.01.036 · Cited by 909 · see citing works
Physical activity levels and patterns of 9- and 15-yr-old European children
RIDDOCH, C. J., BO ANDERSEN, L., WEDDERKOPP, N., HARRO, M., KLASSON-HEGGEBØ, L., SARDINHA, L. B., COOPER, A. R., & EKELUND, U. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000106174.43932.92 · Cited by 900 · see citing works
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., DeFronzo, R. A., EINHORN, D. F., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 874 · see citing works
Giles‐Corti, B. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1115 · Cited by 860 · see citing works
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700 · see citing works
Carnethon, M. R. (2003) · JAMA · doi:10.1001/jama.290.23.3092 · Cited by 691 · see citing works
Infant weight gain and childhood overweight status in a multicenter, cohort study
Stettler, N., Zemel, B. S., Kumanyika, S., & Stallings, V. A. (2002) · Pediatrics · doi:10.1542/peds.109.2.194 · Cited by 687 · see citing works
The global spread of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.042 · Cited by 652 · see citing works
Standards of medical care in diabetes—2016 abridged for primary care providers
American Diabetes Association (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.1.3 · Cited by 520 · see citing works
Type 2 Diabetes in the Young: The Evolving Epidemic
Alberti, K. G. M. M., Zimmet, P., Shaw, J. E., Bloomgarden, Z. T., KAUFMAN, F. R., Silink, M., & for the Consensus Workshop Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1798 · Cited by 490 · see citing works
Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes
Eppens, M. C., Craig, M. E., Cusumano, J. M., Hing, S. J., Chan, A. K. F., Howard, N. J., Silink, M., & Donaghue, K. C. (2006) · Diabetes Care · doi:10.2337/dc05-2470 · Cited by 468 · see citing works
Copeland, K. C., Zeitler, P. S., Geffner, M. E., Guandalini, C., HIGGINS, J. A., Hirst, K., KAUFMAN, F. R., Linder, B. L., Marcovina, S. M., McGuigan, P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1642 · Cited by 464 · see citing works
Socio-economic status, dietary intake and 10 y trends: the Dutch National Food Consumption Survey
Hulshof, K. F. A. M., Brussaard, J. H., Kruizinga, A. G., Telman, J., & Löwik, M. R. H. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601503 · Cited by 439 · see citing works
Evidence for secular trends in children's physical activity behaviour
Dollman, J., Norton, K., & Norton, L. (2005) · British Journal of Sports Medicine · doi:10.1136/bjsm.2004.016675 · Cited by 427 · see citing works
Long-Term Complications and Mortality in Young-Onset Diabetes
Constantino, M. I., Molyneaux, L., Limacher-Gisler, F., Al-Saeed, A., Luo, C., Wu, T., Twigg, S. M., Yue, D. K., & Wong, J. (2013) · Diabetes Care · doi:10.2337/dc12-2455 · Cited by 423 · see citing works
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
Tahrani, A. A., Barnett, A. H., & Bailey, C. J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.86 · Cited by 398 · see citing works
Self-citationEffect of Metformin in Pediatric Patients With Type 2 Diabetes
Jones, K. L., Arslanian, S., Peterokova, V. A., Park, J.-S., & Tomlinson, M. J. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.89 · Cited by 392 · cited 8× · see citing works
“High HbA1c and low insulin secretory capacity at baseline were independent predictors of risk for treatment failure (defined as HbA1c >8% for 6 months) 137.”
InfluentialComplications in Young Adults With Early-Onset Type 2 Diabetes
Hillier, T. A., & Pedula, K. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.2999 · Cited by 387 · see citing works
Acute and chronic complications of type 2 diabetes mellitus in children and adolescents
Pinhas‐Hamiel, O., & Zeitler, P. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60821-6 · Cited by 386 · see citing works
Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities
Nadeau, K. J., Anderson, B. J., Berg, E. G., Chiang, J. L., Chou, H., Copeland, K. C., Hannon, T. S., Huang, T. T.-K., Lynch, J. L., Powell, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1066 · Cited by 381 · see citing works
Diet, nutrition and the prevention of type 2 diabetes
Steyn, N., Mann, J., Bennett, P., Temple, N., Zimmet, P., Tuomilehto, J., Lindström, J., & Louheranta, A. (2004) · Public Health Nutrition · doi:10.1079/phn2003586 · Cited by 367 · see citing works
Type 2 diabetes mellitus in children and adolescents
Reinehr, T. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.270 · Cited by 363 · see citing works
Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents
Copeland, K. C., Silverstein, J., Moore, K. R., Prazar, G. E., Raymer, T., Shiffman, R. N., Springer, S. C., Thaker, V. V., Anderson, M., Spann, S. J., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-3494 · Cited by 323 · see citing works
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
D’Adamo, E., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc11-s212 · Cited by 315 · see citing works
Acculturation and obesity among migrant populations in high income countries – a systematic review
Delavari, M., Sønderlund, A. L., Swinburn, B. A., Mellor, D. J., & Renzaho, A. M. N. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-458 · Cited by 310 · see citing works
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70137-8 · Cited by 296 · see citing works
Bariatric surgery for type 2 diabetes
Dixon, J. B., le Roux, C. W., Rubino, F., & Zimmet, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60401-2 · Cited by 295 · see citing works
TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288 · see citing works
Characteristics of an Adult Population With Newly Diagnosed Type 2 Diabetes
Hillier, T. A., & Pedula, K. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1522 · Cited by 284 · see citing works
Early onset type 2 diabetes: risk factors, clinical impact and management
Wilmot, E., & Idris, I. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314548679 · Cited by 269 · see citing works
Yessoufou, A., & Moutairou, K. (2011) · Experimental Diabetes Research · doi:10.1155/2011/218598 · Cited by 266 · see citing works
Rising Incidence of Type 2 Diabetes in Children in the U.K.
Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. H. (2007) · Diabetes Care · doi:10.2337/dc06-1813 · Cited by 258 · see citing works
Kautiainen, S., Koivusilta, L., Lintonen, T., Virtanen, S. M., & Rimpelä, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802994 · Cited by 238 · see citing works
Huo, X., Gao, L., Guo, L., Xu, W., Wang, W., Zhi, X., Li, L., Ren, Y., Qi, X., Sun, Z., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00508-2 · Cited by 236 · see citing works
Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
Willette, A. A., Xu, G., Johnson, S. C., Birdsill, A. C., Jonaitis, E. M., Sager, M. A., Hermann, B. P., Rue, A. L., Asthana, S., & Bendlin, B. B. (2012) · Diabetes Care · doi:10.2337/dc12-0922 · Cited by 225 · see citing works
Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Newton, K. P., Hou, J., Crimmins, N. A., Lavine, J. E., Barlow, S. E., Xanthakos, S. A., Africa, J. A., Behling, C. A., Donithan, M., Clark, J. M., et al. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.1971 · Cited by 224 · see citing works
Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study
Mayer-Davis, E. J., Nichols, M., Liese, A. D., Bell, R. A., Dabelea, D. M., Johansen, J. M., Pihoker, C., Rodriguez, B. L., Thomas, J., & Williams, D. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.02.002 · Cited by 220 · see citing works
Socioeconomic Status and Incidence of Type 2 Diabetes: Results From the Black Women's Health Study
Krishnan, S., Cozier, Y. C., Rosenberg, L. A., & Palmer, J. R. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp443 · Cited by 211 · see citing works
Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents
(2021) · American Academy of Pediatrics eBooks · doi:10.1542/9781610025034-part01-management · Cited by 198 · see citing works
Knowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194 · see citing works
Burden of Diabetes on the Ability to Work
Breton, M.-C., Guénette, L., Amiche, M. A., Kayibanda, J. F., Grégoire, J., & Moisan, J. (2013) · Diabetes Care · doi:10.2337/dc12-0354 · Cited by 188 · see citing works
Gungor, N., Bacha, F., Saad, R., Janosky, J., & Arslanian, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.638 · Cited by 186 · see citing works
High Burden of Kidney Disease in Youth-Onset Type 2 Diabetes
Dart, A. B., Sellers, E. A. C., Martens, P. J., Rigatto, C., Brownell, M. D., & Dean, H. (2012) · Diabetes Care · doi:10.2337/dc11-2312 · Cited by 181 · see citing works
Merlotti, C., Morabito, A., & Pontiroli, A. E. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12270 · Cited by 165 · see citing works
Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis
Chan, J. C. N., Lau, E. S. H., Luk, A. O. Y., Cheung, K. K.-T., Kong, A. P. S., Yu, L. W. L., Choi, K. C., Chow, F. C. C., Ozaki, R., Brown, N., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.018 · Cited by 162 · see citing works
Rhodes, E. T., Prosser, L., Hoerger, T. J., Lieu, T. A., Ludwig, D. S., & Laffel, L. M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03542.x · Cited by 161 · see citing works
Song, S. H., & Hardisty, C. A. (2009) · QJM · doi:10.1093/qjmed/hcp121 · Cited by 150 · see citing works
Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome
Joham, A. E., Ranasinha, S., Zoungas, S., Moran, L., & Teede, H. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2007 · Cited by 150 · see citing works
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium
KLINGENSMITH, G. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Haro, H., Wood, J., Lee, J. M., Willi, S. M., Cengiz, E., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12281 · Cited by 141 · see citing works
Is male fertility associated with type 2 diabetes mellitus?
Bener, A., Al-Ansari, A. A., Zirie, M. A., & Al-Hamaq, A. O. A. A. (2009) · International Urology and Nephrology · doi:10.1007/s11255-009-9565-6 · Cited by 137 · see citing works
Gustat, J., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00427-4 · Cited by 135 · see citing works
Kalra, S., Vithalani, M., Gulati, G., Kulkarni, C. M., Kadam, Y., Pallivathukkal, J. K., Das, B., Sahay, R. K., & Modi, K. D. (2013) · PubMed · Cited by 133 · see citing works
Luk, A. O. Y., Lau, E. S. H., So, W., Ronald, C. W., Kong, A. P. S., Ozaki, R., Chow, F. C. C., & Chan, J. C. N. (2013) · Diabetes Care · doi:10.2337/dc13-1336 · Cited by 124 · see citing works
The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010
Holden, S. E., Barnett, A. H., Peters, J. R., Jenkins‐Jones, S., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12123 · Cited by 122 · see citing works
Self-citationSocioeconomic Status and Incident Type 2 Diabetes Mellitus: Data from the Women's Health Study
Lee, T. C., Glynn, R. J., Peña, J. M., Paynter, N. P., Conen, D., Ridker, P. M., Pradhan, A. D., Buring, J. E., & Albert, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027670 · Cited by 116 · see citing works
Portrait, F. R. M., Teeuwiszen, E., & Deeg, D. J. H. (2011) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.04.005 · Cited by 113 · see citing works
Jaiswal, M., Lauer, A., Martin, C. L., Bell, R. A., Divers, J., Dabelea, D., Pettitt, D. J., Saydah, S., Pihoker, C., Standiford, D. A., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1213 · Cited by 108 · see citing works
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00915.x · Cited by 106 · see citing works
Deteriorating beta–cell function in type 2 diabetes: a long–term model
Bagust, A., & Beale, S. (2003) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcg040 · Cited by 105 · see citing works
Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring
Vrachnis, N., Antonakopoulos, N., Iliodromiti, Z., Dafopoulos, K., Siristatidis, C., Pappa, K. I., Deligeoroglou, E., & Vitoratos, N. (2012) · Experimental Diabetes Research · doi:10.1155/2012/538474 · Cited by 103 · see citing works
Burns, N. C., Finucane, F. M., Hatunic, M., Gilman, M., Murphy, M. S., Gasparro, D., Mari, A., Gastaldelli, A., & Nolan, J. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0655-7 · Cited by 96 · see citing works
SHAH, A. S., Dolan, L. M., Kimball, T. R., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2039 · Cited by 96 · see citing works
Association Between Maternal Diabetes in Utero and Age at Offspring's Diagnosis of Type 2 Diabetes
Pettitt, D. J., Lawrence, J. M., Beyer, J., Hillier, T. A., Liese, A. D., Mayer-Davis, B., Loots, B., Imperatore, G., Liu, L. L., Dolan, L. M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0769 · Cited by 94 · see citing works
Characterization of insulin secretion and resistance in type 2 diabetes of adolescents
Druet, C., Tubiana-Rufi, N., Chevenne, D., Rigal, O., Polak, M., & Levy-Marchal, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1672 · Cited by 93 · see citing works
Early life factors and type 2 diabetes mellitus
Jiang, X., Ma, H., Wang, Y., & Liu, Y. (2013) · Journal of Diabetes Research · doi:10.1155/2013/485082 · Cited by 92 · see citing works
Browne, J. L., Nefs, G., Pouwer, F., & Speight, J. (2014) · Diabetic Medicine · doi:10.1111/dme.12566 · Cited by 90 · see citing works
Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population
Song, S. H. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000044 · Cited by 89 · see citing works
Familial Early-Onset Type 2 Diabetes in Chinese Patients
Ng, M. C. Y., Lee, S., Ko, G. T. C., Li, J. K. Y., So, W., Hashim, Y., Barnett, A. H., Mackay, I. R., Critchley, J., Cockram, C. S., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.663 · Cited by 83 · see citing works
Self-citationMohan, V., Amutha, A., Ranjani, H., Unnikrishnan, R., Datta, M., Anjana, R. M., Staimez, L., Ali, M. K., & Narayan, K. M. V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0259 · Cited by 82 · see citing works
Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet
Willi, S. M., Martin, K. L., Datko, F. M., & Brant, B. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.348 · Cited by 81 · see citing works
Reinehr, T., Schober, E., Roth, C. L., Wiegand, S., & Holl, R. W. (2007) · Hormone Research in Paediatrics · doi:10.1159/000111814 · Cited by 80 · see citing works
Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
Zhou, K., Donnelly, L. A., Morris, A. D., Franks, P. W., Jennison, C., Palmer, C. N. A., & Pearson, E. R. (2013) · Diabetes Care · doi:10.2337/dc13-1995 · Cited by 79 · see citing works
Abouzeid, M., Philpot, B., Janus, E. D., Coates, M. J., & Dunbar, J. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-252 · Cited by 79 · see citing works
Assessing and treating insulin resistance in women with polycystic ovarian syndrome
Traub, M. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i3.33 · Cited by 77 · see citing works
Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience
KLINGENSMITH, G. J., Pyle, L., Nadeau, K. J., Barbour, L. A., Goland, R., Willi, S. M., Linder, B. L., White, N. H., & for the TODAY Study Group (2015) · Diabetes Care · doi:10.2337/dc15-1206 · Cited by 75 · see citing works
Arslanian, S. A., Pyle, L. L., Payan, M., Bacha, F. F., Caprio, S., Haymond, M. W., Levitsky, L. L., Goland, R., White, N. H., & Sm, W. (2013) · Diabetes Care · Cited by 75 · see citing works
The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth
Gow, M., Garnett, S., Baur, L., & Lister, N. (2016) · Nutrients · doi:10.3390/nu8080486 · Cited by 70 · see citing works
Etiology of insulin resistance in youth with type 2 diabetes
Cree-Green, M., Triolo, T. M., & Nadeau, K. J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0341-0 · Cited by 69 · see citing works
Mcgavock, J., Sellers, E., & Dean, H. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.057 · Cited by 65 · see citing works
Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes
Molyneaux, L. M., Constantino, M., & Yue, D. K. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00330.x · Cited by 63 · see citing works
Prevention and Treatment of Type 2 Diabetes in Youth
Libman, I. M., & Arslanian, S. A. (2006) · Hormone Research in Paediatrics · doi:10.1159/000095981 · Cited by 62 · see citing works
Kelsey, M. M., Geffner, M. E., Guandalini, C., Pyle, L., Tamborlane, W. V., Zeitler, P. S., White, N. H., & for the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study Group (2015) · Pediatric Diabetes · doi:10.1111/pedi.12264 · Cited by 60 · see citing works
Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
McGavock, J., Dart, A. B., & Wicklow, B. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0568-z · Cited by 60 · see citing works
Chuang, L.-M., Soegondo, S., Soewondo, P., Young-Seol, K., Mohamed, M., Dalisay, E., Go, R., Lee, W., Tong-Yuan, T., Tandhanand, S., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.05.007 · Cited by 58 · see citing works
Talbott, E. O., Zborowski, J. V., Rager, J. R., Kip, K. E., Xu, X., & Orchard, T. J. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0098 · Cited by 56 · see citing works
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S. E., Davidson, M., EINHORN, D. F., Garber, J. R., et al. (2015) · Endocrine Practice · doi:10.4158/ep151063.cs · Cited by 55 · see citing works
Anuradha, S., Radha, V., & Mohan, V. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01577.x · Cited by 54 · see citing works
Reinehr, T., Karges, B., Meissner, T., Wiegand, S., Stoffel-Wagner, B., Holl, R. W., & Woelfle, J. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.055 · Cited by 51 · see citing works
Sensorineural Hearing Loss-A Common Finding in Early-Onset Type 2 Diabetes Me Llitus
Lerman‐Garber, I., Ramos, D. C., Valdés, S., et al. (2012) · Endocrine Practice · doi:10.4158/ep11389.or · Cited by 51 · see citing works
Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population1
Aguilar-Salinas, C. A., Reyes-Rodríguez, E., Ordóñez-Sánchez, M. L., Torres, M. A., Ramı́rez-Jiménez, S., Domínguez‐López, A., Martínez‐François, J. R., Velasco-Pérez, M. L., Salazar, M. A., García‐García, E., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7134 · Cited by 51 · see citing works
Spencer‐Bonilla, G., Rodríguez‐Gutiérrez, R., & Montori, V. M. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2952 · Cited by 50 · see citing works
Hearing Loss in Middle-aged Subjects with Type 2 Diabetes Mellitus
Ren, J., Zhao, P., Chen, L., et al. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.10.003 · Cited by 47 · see citing works
Prevention of type 2 diabetes in young people: a theoretical perspective
Huang, T. T. ‐., & Goran, M. I. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2003.00022.x · Cited by 45 · see citing works
George, M. M., & Copeland, K. C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0334-z · Cited by 45 · see citing works
Early-onset type 2 diabetes: High risk for premature diabetic retinopathy
Song, S. H., & Gray, T. A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.030 · Cited by 44 · see citing works
Frayling, T. M., Wiltshire, S., Hitman, G. A., Walker, M., Lévy, J., Sampson, M., Groves, C. J., Menzel, S., McCarthy, M. I., & Hattersley, A. T. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1857 · Cited by 43 · see citing works
Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes
Gunathilake, W., Song, S. H., Sridharan, S., Fernando, D., & IDRIS, I. R. (2010) · QJM · doi:10.1093/qjmed/hcq135 · Cited by 41 · see citing works
Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population
Aguilar-Salinas, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.220 · Cited by 38 · see citing works
Benhalima, K., Song, S. H., Wilmot, E. G., Khunti, K. K., Gray, L. J., Lawrence, I. G., & Davies, M. J. (2011) · Primary care diabetes · doi:10.1016/j.pcd.2011.06.003 · Cited by 37 · see citing works
Jiménez-Corona, A., Rojas, R., Gómez-Pérez, F. J., & Aguilar-Salinas, C. A. (2010) · Salud Pública de México · doi:10.1590/s0036-36342010000700006 · Cited by 36 · see citing works
Success with lifestyle monotherapy in youth with new-onset type 2 diabetes
Wittmeier, K. D., Wicklow, B. A., Sellers, E. A., Griffith, A. T., Dean, H. J., & McGavock, J. M. (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.3.129 · Cited by 32 · see citing works
Kim, K.-S., Oh, H.-J., Kim, J.-W., Lee, Y.-K., Kim, S.-K., Park, S.-W., Kim, Y.-L., Park, W.-K., & Cho, Y.-W. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.2.119 · Cited by 28 · see citing works
Nonalcoholic Fatty Liver Disease and Insulin Resistance in Youth
Bloomgarden, Z. T. (2007) · Diabetes Care · doi:10.2337/dc07-zb06 · Cited by 28 · see citing works
Familial early onset of type-2 diabetes mellitus and its complications.
Jali, M. V., Kambar, S., Jali, S. M., & Gowda, S. (2009) · Europe PMC (PubMed Central) · doi:10.4297/najms.2009.7377 · Cited by 28 · see citing works
Taha, Umpaichitra, Banerji, & Castells (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.2.135 · Cited by 26 · see citing works
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children
Hecht, L., & Weiss, R. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0448-y · Cited by 26 · see citing works
Serrano, O. K., Zhang, Y., Kintzer, E., Moran-Atkin, E., Choi, J., Melvin, W. S., & Camacho, D. R. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-4849-2 · Cited by 25 · see citing works
Hasson, R. E., Adam, T. C., Pearson, J. A., Davis, J. N., Spruijt‐Metz, D., & Goran, M. I. (2013) · Journal of Obesity · doi:10.1155/2013/512914 · Cited by 24 · see citing works
Nephropathy in Youth and Young Adults with Type 2 Diabetes
Solis‐Herrera, C., Triplitt, C. L., & Lynch, J. L. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0456-y · Cited by 23 · see citing works
Mast, R., Jansen, A. P. D., Walraven, I., Rauh, S. P., van der Heijden, A. A. W. A., Heine, R. J., Elders, P. J. M., Dekker, J. M., Nijpels, G., & Hugtenburg, J. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1149 · Cited by 21 · see citing works
Type 2 Diabetes Mellitus in the Pediatric Population
Gaylor, A. S., & Condren, M. E. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.9.871.36099 · Cited by 18 · see citing works
Gragnoli, C., Preussenthal, G. M. V., & Habener, J. F. (2004) · Metabolism · doi:10.1016/j.metabol.2004.03.003 · Cited by 16 · see citing works
Review: Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk?
Song, S. H. (2008) · The British Journal of Diabetes · doi:10.1177/14746514080080020201 · Cited by 15 · see citing works
Significant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation
Song, S. H. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12789 · Cited by 15 · see citing works
Prevalence of the metabolic syndrome in young adults
Morrell, J. S., Burke, J. D., Lofgren, I. E., et al. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.5.a111-d · Cited by 15 · see citing works
Gu, W., Huang, Y., Zhang, Y., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12335 · Cited by 13 · see citing works
Katulanda, G. W., Katulanda, P., Adler, A., Peiris, S. R., Draisey, I., Wijeratne, S., Sheriff, R., Matthews, D. R., & Shine, B. S. F. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009080 · Cited by 13 · see citing works
Clinical and laboratory features of youth onset type 2 diabetes in Jamaica.
Tulloch-Reid, M. K., Boyne, M. S., Smikle, M. F., Choo-Kang, E. G., Parkes, R. H., Wright-Pascoe, R., Barton, E., Wilks, R., & Williams, D. E. (2010) · PubMed · Cited by 11 · see citing works
DIAMAP: A Road Map for Diabetes Research in Europe
Hills, S., & Halban, P. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500334 · Cited by 11 · see citing works
Pros and cons of bariatric surgery in adolescents
Mingrone, G. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30425-9 · Cited by 11 · see citing works
Song, S. H., & Gray, T. A. (2012) · QJM · doi:10.1093/qjmed/hcs113 · Cited by 9 · see citing works
Tanaka, S., Kobayashi, T., Tomura, H., et al. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978656 · Cited by 9 · see citing works
Miglani, S., Goswami, R., Tandon, N., et al. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.01.005 · Cited by 9 · see citing works
Saydah, S., Imperatore, G., Henkin, L. F., D’Agostino, R., Divers, J., Mayer‐Davis, E. J., Dabelea, D., KLINGENSMITH, G. J., Pihoker, C., & Lawrence, J. M. (2015) · Diabetes Care · doi:10.2337/dc15-0157 · Cited by 8 · see citing works
Ageing brain abnormalities in young obese patients with type 2 diabetes: a cause for concern
Nolan, J. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1890-x · Cited by 7 · see citing works
The Policy Puzzle: the diabetes maze in Europe
Day, C. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411431590 · Cited by 6 · see citing works
Nizam, S., Khalequzzaman, M., Yatsuya, H., et al. (2012) · PubMed · doi:10.18999/nagjms.74.1-2.149 · Cited by 4 · see citing works
Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
McIntyre, D. H. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s13791 · Cited by 4 · see citing works
Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
McIntyre (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s13791
Flagged first, then by citations
3 of the 150 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01655-5 · Cited by 1,120 · see citing works
Physical activity behaviours in adolescence: Current evidence and opportunities for intervention
van Sluijs, E. M. F., Ekelund, U., Crochemore-Silva, I., Guthold, R., Ha, A., Lubans, D., Oyeyemi, A. L., Ding, D., & Katzmarzyk, P. T. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01259-9 · Cited by 919 · see citing works
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724 · see citing works
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. (2022) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 649 · see citing works
Trends in diabetes treatment and control in U.S. adults, 1999-2018
Fang, M., Wang, D., Coresh, J., & Selvin, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmsa2032271 · Cited by 690 · see citing works
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
Wang, L., Li, X., Wang, Z., Bancks, M. P., Carnethon, M. R., Greenland, P., Feng, Y., Wang, H., & Zhong, V. W. (2021) · JAMA · doi:10.1001/jama.2021.9883 · Cited by 587 · see citing works
Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0334-z · Cited by 483 · see citing works
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 408 · see citing works
Zhang, Y., Pan, X., Chen, J., Xia, L., Cao, A., Zhang, Y., Wang, J., Li, H., YANG, K. Y., Guo, K., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-04985-9 · Cited by 359 · see citing works
Pearson-Stuttard, J., Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., & Gregg, E. W. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30431-9 · Cited by 335 · see citing works
Młynarska, E., Czarnik, W., Kurys, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031094 · Cited by 421 · see citing works
“T2DM is a complex, multisystemic metabolic disorder characterized by high blood glucose levels resulting from a progressive defect in insulin secretion or tissue resistance to insulin [4,5].”
Bendor, C. D., Bardugo, A., Pinhas‐Hamiel, O., Afek, A. B., & Twig, G. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01052-1 · Cited by 327 · see citing works
Xie, J., Wang, M., Long, Z., Ning, H., Li, J., Cao, Y., Liao, Y., Liu, G., Wang, F., & Pan, A. (2022) · BMJ · doi:10.1136/bmj-2022-072385 · Cited by 320 · see citing works
Highlighting Diabetes Mellitus
Schmidt, A. M. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310221 · Cited by 292 · see citing works
Nutrition and Food Literacy: Framing the Challenges to Health Communication
Silva, P., Araújo, R., Lopes, F., & Ray, S. (2023) · Nutrients · doi:10.3390/nu15224708 · Cited by 267 · see citing works
“Obesity, for example, is one of the major risks for heart failure [94], type 2 diabetes [95], hypertension, and coronary heart disease [96].”
BackgroundMechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
Sha, W., Hu, F., Yang, X., Chu, Y., & Bu, S. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9999612 · Cited by 273 · see citing works
Aggarwal, R., Yeh, R. W., Maddox, K. E. J., & Wadhera, R. K. (2023) · JAMA · doi:10.1001/jama.2023.2307 · Cited by 273 · see citing works
Global burden of NAFLD and chronic liver disease among adolescents and young adults
Paik, J. M., Kabbara, K. W., Eberly, K. E., Younossi, Y., Henry, L. L., & Younossi, Z. M. (2021) · Hepatology · doi:10.1002/hep.32228 · Cited by 250 · see citing works
Diabetes: A metabolic and reproductive disorder in women
Thong, E. P., Codner, E., Laven, J. S. E., & Teede, H. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30345-6 · Cited by 242 · see citing works
Horesh, A., Tsur, A. M., Bardugo, A., & Twig, G. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00439-9 · Cited by 242 · see citing works
Feig, D. S., Donovan, L. E., Zinman, B., Sanchez, J. J., Asztalos, E., Ryan, E. A., Fantus, I. G., Hutton, E., Armson, A. B., Lipscombe, L. L., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30310-7 · Cited by 234 · see citing works
Managing Atherosclerotic Cardiovascular Risk in Young Adults
Stone, N. J., Smith, S. C., Orringer, C. E., Rigotti, N. A., Návar, A. M., Khan, S. S., Jones, D. W., Goldberg, R. B., Mora, S., Blaha, M. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.016 · Cited by 250 · see citing works
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer
Chen, H., Zheng, X., Zong, X., Li, Z., Li, N., Hur, J., Fritz, C. D. L., Chapman, W. C., Nickel, K. B., Tipping, A. D., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321661 · Cited by 230 · see citing works
Current insights and emerging trends in early-onset type 2 diabetes
Misra, S., Ke, C., Srinivasan, S., Goyal, A., Nyrienda, M. J., Florez, J. C., Khunti, K. K., Magliano, D. J., & Luk, A. O. Y. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00225-5 · Cited by 239 · see citing works
Condorelli, R. A., La Vignera, S., Mongioì, L. M., Alamo, A., & Calogero, A. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00268 · Cited by 197 · see citing works
“org May 2018 | Volume 9 | Article 268 at diagnosis with DM2 is particularly interesting and worrying because leads to longer lifetime exposure to hyperglycemia and long-term complications (4).”
BackgroundGooding, H. C., Gidding, S. S., Moran, A. E., Redmond, N., Allen, N. B., Bacha, F. F., Burns, T. L., Catov, J. M., Grandner, M. A., Harris, K. M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016115 · Cited by 193 · see citing works
Global, Regional, and National Epidemiology of Diabetes in Children From 1990 to 2019
Zhang, K., Kan, C., Han, F., Zhang, J., Ding, C., Guo, Z., Huang, N., Zhang, Y., Hou, N., & Sun, X. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2023.2029 · Cited by 174 · see citing works
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents
SHAH, A. S., Zeitler, P. S., Wong, J., Peña, A. S., Wicklow, B. A., Arslanian, S. A., CHANG, N. T., Fu, J., Dabadghao, P., Pinhas‐Hamiel, O., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13409 · Cited by 171 · see citing works
“The prevalence ratio of girls to boys is reported as 6:1 for First Nations youth in Canada, 5:1 for Pima Indian, 3:1 for Mexican Americans and 1.2:1 for Japanese.35,48,49 Similar sex differences are found in Taiwan but not in studies from China.22,35,50 These sex differences are not well understood and may be due to d…”
BackgroundInfluentialCarter, M. J., DaVanzo, J., Haught, R., Nusgart, M., Cartwright, D., & Fife, C. E. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2232256 · Cited by 170 · see citing works
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B. M., Ghosh, S. K., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 175 · see citing works
“[184] TZDs have demonstrated beneficial effects in attenuating dyslipidaemia commonly observed in patients with chronic T2DM.”
BackgroundResultInfluentialAlderete, T., Jin, R., Walker, D., Valvi, D., Chen, Z.-H., Jones, D. P., Peng, C., Gilliland, F., Berhane, K., Conti, D., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.02.047 · Cited by 148 · see citing works
Adolescent Obesity and Early-Onset Type 2 Diabetes
Twig, G., Zucker, I., Afek, A., Cukierman-Yaffe, T., Bendor, C. D., Derazne, E., Lutski, M., Shohat, T., Mosenzon, O., Tzur, D., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1988 · Cited by 161 · see citing works
“Diabetes affects over 400 million people worldwide, and the global prevalence has been growing, with a disproportionate increase at young ages (1).”
BackgroundArmocida, B., Monasta, L., Sawyer, S., Bustreo, F., Segafredo, G., Castelpietra, G., Ronfani, L., Pasovic, M., Hay, S., Armocida, B., et al. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00073-6 · Cited by 161 · see citing works
“32 Additionally, considering the rising trend of disability due to diabetes, the alarming increase of type 2 diabetes in adolescents, 33,34 and longterm effects of COVID19 on obesity and type 1 diabetes, reasonable prevention strategies and health system responses should be prioritised.”
BackgroundMetformin, Macrophage Dysfunction and Atherosclerosis
Feng, X., Chen, W., Ni, X., Little, P. J., Xu, S., Tang, L., & Weng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682853 · Cited by 153 · see citing works
“In HFD-fed apoE-/- mice and macrophages, metformin treatment also showed significant RCT. Mechanism studies have shown that AMPK activates HDL in mice, with higher paraoxonase 1 activity, lower myeloperoxidase activity and lower HDL inflammation index.”
BackgroundMethodInfluentialRecent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146 · see citing works
“The majority of circulating GIP refers to GIP(1-42), which gets cleaved from proGIP in the intestine by the action of PC1/3, but also a shorter form, GIP(130NH2), is produced in the intestine and the pancreatic a-cells by cleavage of proGIP by PC2 (149).”
BackgroundInfluentialEsteve, M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00111 · Cited by 142 · see citing works
Jitraknatee, J., Ruengorn, C., & Nochaiwong, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63443-4 · Cited by 143 · see citing works
Early onset type 2 diabetes mellitus: an update
Strati, M., Moustaki, M., Ψαλτοπούλου, Θ., Vryonidou, A., & Paschou, S. Α. (2024) · Endocrine · doi:10.1007/s12020-024-03772-w · Cited by 142 · see citing works
“Early-onset T2DM is strongly associated with obesity, metabolic syndrome features, insulin resistance, family history, and necessitates faster progression to insulin therapy, i.e., in 2 – 5 years after diagnosis in >50% of patients [2].”
BackgroundResultInfluentialYouth-onset type 2 diabetes mellitus: an urgent challenge
Bjornstad, P., Chao, L. C., Cree‐Green, M., Dart, A. B., King, M., Looker, H. C., Magliano, D. J., Nadeau, K. J., Pinhas‐Hamiel, O., SHAH, A. S., et al. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00645-1 · Cited by 136 · see citing works
Madsen, M. S. A., Holm, J. B., Pallejá, A., Wismann, P., Fabricius, K., Rigbolt, K. T. G., Mikkelsen, M., Sommer, M. O. A., Jelsing, J., Nielsen, H. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52103-x · Cited by 125 · see citing works
Diabetic retinopathy: Screening, prevention, and treatment
Chong, D. D., Das, N., & Singh, R. P. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.24028 · Cited by 121 · see citing works
Marselli, L., Piron, A., Suleiman, M., Colli, M. L., Yi, X., Khamis, A., Carrat, G., Rutter, G. A., Bugliani, M., Giusti, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108466 · Cited by 115 · see citing works
Wearable, Sensing-Controlled, Ultrasound-Based Microneedle Smart System for Diabetes Management
Luo, X., Yu, Q., Yang, L., & Cui, Y. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02863 · Cited by 109 · see citing works
Luo, X., Yu, Q., Liu, Y., Gai, W., Ye, L., Yang, L., & Cui, Y. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02337 · Cited by 101 · see citing works
Molecular basis of ageing in chronic metabolic diseases
Spinelli, R., Parrillo, L., Longo, M., Florese, P., Desiderio, A., Zatterale, F., Miele, C., Raciti, G. A., & Bèguinot, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01255-z · Cited by 100 · see citing works
“In addition, SIRT1 expression in SAT is inversely correlated with BMI and ATM content [106, 107], while its expression in VAT is negatively correlated with BMI and waist circumference [105, 106].”
BackgroundInfluentialThe role of structural racism and geographical inequity in diabetes outcomes
Agarwal, S., Wade, A. N., Mbanya, J. C., Yajnik, C., Thomas, N., Egede, L. E., Campbell, J. A., Walker, R. J., Maple-Brown, L., & Graham, S. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00909-1 · Cited by 97 · see citing works
Inflammasomes and type 2 diabetes: An updated systematic review
Sepehri, Z., Kiani, Z., Afshari, M., Kohan, F., Dalvand, A., & Ghavami, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.10.010 · Cited by 95 · see citing works
The regulation of PKA signaling in obesity and in the maintenance of metabolic health
London, E., & Stratakis, C. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108113 · Cited by 95 · see citing works
Bioactivities and Mechanism of Actions of Dendrobium officinale: A Comprehensive Review
Xu, X., Zhang, C., Wang, N., Xu, Y., Tang, G., Xu, L., & Feng, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6293355 · Cited by 92 · see citing works
“The rapid development of modern society leads to unhealthy eating behavior, less physical activities, and overloaded stress management, which increases the risk of diabetes in adolescents and young adults [62].”
BackgroundCharacterizing Multimorbidity from Type 2 Diabetes
Cicek, M., Buckley, J., Pearson-Stuttard, J., & Gregg, E. W. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.012 · Cited by 91 · see citing works
Ge, L., Ong, R., Yap, C. W., & Heng, B. H. (2018) · Nursing and Health Sciences · doi:10.1111/nhs.12585 · Cited by 88 · see citing works
Ravaut, M., Harish, V., Sadeghi, H., Leung, K. K., Volkovs, M., Kornas, K., Watson, T., Poutanen, T., & Rosella, L. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11315 · Cited by 90 · see citing works
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Yin, R., Xu, Y., Wang, X., Yang, L., & Zhao, D. (2022) · Molecules · doi:10.3390/molecules27103055 · Cited by 95 · see citing works
“Excess body fat along with age constitute the two most important risk factors for the premature development of T2DM [15,16].”
BackgroundYaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7796727 · Cited by 91 · see citing works
“But substantial changes in modern lifestyle towards lower physical activity have also increased the prevalence of DM in young adults [6, 7].”
BackgroundContributions of physical inactivity and sedentary behavior to metabolic and endocrine diseases
Kerr, N. R., & Booth, F. W. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.09.002 · Cited by 88 · see citing works
Savage, M. J., Hennis, P. J., Magistro, D., Donaldson, J., Healy, L. C., & James, R. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18062930 · Cited by 85 · see citing works
Porcine models for studying complications and organ crosstalk in diabetes mellitus
Renner, S., Blutke, A., Clauß, S., Deeg, C. A., Kemter, E., Merkus, D., Wanke, R., & Wolf, E. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03158-9 · Cited by 88 · see citing works
The Productivity Burden of Diabetes at a Population Level
Magliano, D. J., Martin, V. J., Owen, A. J., Zomer, E., & Liew, D. (2018) · Diabetes Care · doi:10.2337/dc17-2138 · Cited by 83 · see citing works
“Also compelling is the fact that the prevalence ofdiabetes isexpected tocontinue to riseamongyoungerpeopleasoverweightandobesity become more common (1).”
BackgroundDiabetes Fact Sheets in Korea 2024
Park, S. E., Ko, S., Kim, J. Y., Kim, K., Moon, J. H., Kim, N. H., Han, K., Choi, S. H., & Soo, B. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0818 · Cited by 89 · see citing works
“The earlier onset of diabetes leads to longer lifetime exposure to hyperglycemia and, consequently, a greater propensity for long-term complications [29].”
Abudureyimu, M., Luo, X., Wang, X., Sowers, J. R., Wang, W., Ge, J., Ren, J. T., & Zhang, Y. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac028 · Cited by 82 · see citing works
“…exhibit various types of HF, including HF with preserved, reduced, and midrange ejection ntroduction The prevalence of type 2 diabetes mellitus ( T2DM or T2D ) ose dramatically over the past decades, afflicting ∼8% adults lobally ( Ren et al., 2010 ; Lascar et al., 2018 ; Zhang et al., 018 ) .”
BackgroundChang, V. C., Cotterchio, M., De, P., & Tinmouth, J. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01456-8 · Cited by 74 · see citing works
Yan, F., Li, N., Yue, Y., Wang, C., Zhao, L., Evivie, S. E., Li, B., & Huo, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02855 · Cited by 76 · see citing works
Chen, X., Zhang, L., & Chen, W. (2025) · BMC Medicine · doi:10.1186/s12916-025-03890-w · Cited by 73 · see citing works
“More importantly, increasing evidence indicates that diabetes diagnosed at a younger age poses a greater risk, leading to the premature development of multimorbidity, with adverse effects on quality of life and long-term outcomes, increasing the possibility of future public health [8, 9].”
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71 · see citing works
Liu, R., Li, L., Shao, C., Cai, H., & Wang, Z. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1531289 · Cited by 74 · see citing works
“Diabetes, especially type 2 diabetes, shows a trend of younger onset, and it is more characteristic for adolescents to have an increased incidence of diabetes [51].”
BackgroundA Nomogram for Predicting Stroke Recurrence Among Young Adults
Yuan, K., Chen, J., Xu, P., Zhang, X., Gong, X., Wu, M. F., Xie, Y., Wang, H., Xu, G., & Liu, X. (2020) · Stroke · doi:10.1161/strokeaha.120.029740 · Cited by 67 · see citing works
Davis, G. M., Peters, A. L., Bode, B. W., Carlson, A. L., Dumais, B., Vienneau, T. E., Huyett, L. M., & Ly, T. T. (2023) · Diabetes Care · doi:10.2337/dc22-1915 · Cited by 69 · see citing works
Ke, C., Stukel, T. A., Shah, B. R., Lau, E. S. H., Ronald, C. W., So, W., Kong, A. P. S., Chow, E., Chan, J. C. N., & Luk, A. O. Y. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003316 · Cited by 66 · see citing works
Diabetes and all-cause mortality, a 18-year follow-up study
Salehidoost, R., Mansouri, A., Amini, M., Yamini, S. A., & Aminorroaya, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-60142-y · Cited by 60 · see citing works
Wounds under diabetic milieu: The role of immune cellar components and signaling pathways
Lin, S., Wang, Q., Huang, X., Feng, J., Wang, Y., Shao, T., Deng, X., Cao, Y., Chen, X.-H., Zhou, M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114052 · Cited by 62 · see citing works
Bardugo, A., Bendor, C. D., Rotem, R. S., Tsur, A. M., Derazne, E., Gerstein, H. C., Tzur, D., Pinhas-Hamiel, O., Cukierman-Yaffe, T., Raz, I., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00062-1 · Cited by 61 · see citing works
Yuan, M., Sun, T., Zhang, Y., Guo, C., Wang, F., Yao, Z., & Yu, L. (2024) · Nutrients · doi:10.3390/nu16121870 · Cited by 59 · see citing works
“In recent years, the prevalence of young-onset T2DM, which is associated with earlier onset of chronic complications and higher risk of early death [4,5], has been dramatically increasing [6].”
BackgroundDibato, J. E., Montvida, O., Zaccardi, F., Sargeant, J. A., Davies, M. J., Khunti, K. K., & Paul, S. K. (2020) · Diabetes Care · doi:10.2337/dc20-2045 · Cited by 58 · see citing works
Wu, H., Lau, E. S. H., Yang, A., Fan, B., Ronald, C. W., Kong, A. P. S., Chow, E., So, W. Y., Chan, J. C. N., & Luk, A. O. Y. (2021) · Diabetologia · doi:10.1007/s00125-021-05494-4 · Cited by 57 · see citing works
“The number of young people, aged 20–39 years, living with type 2 diabetes had more than doubled from 23 million in 2000 to 63 million in 2013 worldwide, with the most rapid increases occurring in the Western Pacific region [4].”
BackgroundHuang, C., Lee, C., Sung, H.-Y., Liu, S., Liang, P.-C., & Tsai, M.-C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab675 · Cited by 60 · see citing works
“In addition, as the population of individuals with youngonset type 2 DM is growing worldwide (41), we conducted another subgroup analysis using age 40”
MethodMerabet, N., Lucassen, P. J., Crielaard, L., Stronks, K., Quax, R., Sloot, P. M. A., la Fleur, S. E., & Nicolaou, M. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100972 · Cited by 62 · see citing works
Urban–rural disparities in diabetes-related mortality in the USA 1999–2019
Kobo, O. M., Spall, H. G. C. V., & Mamas, M. A. (2022) · Diabetologia · doi:10.1007/s00125-022-05785-4 · Cited by 53 · see citing works
“Early-onset type 2 diabetes is associated with more aggressive disease and higher rates of premature complications [5].”
BackgroundLing, S., Zaccardi, F., Issa, E., Davies, M. J., Khunti, K. K., & Brown, K. (2023) · Diabetologia · doi:10.1007/s00125-022-05854-8 · Cited by 52 · see citing works
“At the same time, the more proactive identification of cases of type 2 diabetes earlier in the trajectory of the disease, alongside changes in diagnostic criteria, the increasing incidence of early-onset type 2 diabetes [22] and the availability of newer glucose-lowering treatments with robust cardioprotective effects…”
BackgroundXin, Y., Davies, A., Briggs, A., McCombie, L., Messow, C. M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05224-2 · Cited by 52 · see citing works
Sandoval-Ramírez, B. A., Catalán, Ú., Llauradó, E., Valls, R. M., Salamanca-Gonzalez, P., Rubió, L., Yuste, S., & Solà, R. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab086 · Cited by 52 · see citing works
Network pharmacology of bioactives from Sorghum bicolor with targets related to diabetes mellitus
Oh, K., Adnan, M., & Cho, D. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240873 · Cited by 50 · see citing works
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
Li, C., Yang, J., Wang, Y., Qi, Y., Yang, W., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01247 · Cited by 50 · see citing works
“Over the past few decades, the obesity rate and prevalence of T2D have increased significantly worldwide (Lascar et al., 2018; Bluher, 2019).”
BackgroundMultimorbidity, Frailty and Diabetes in Older People–Identifying Interrelationships and Outcomes
Sinclair, A. J., & Abdelhafiz, A. H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111911 · Cited by 54 · see citing works
“Another factor is the increased number of younger people diagnosed with diabetes who live long enough to develop other chronic conditions at older age [4].”
BackgroundYouth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost
Marranzini-Rodriguez, I., & O’Sullivan, K. L. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01501-7 · Cited by 53 · see citing works
Misra, S., Holman, N., Barron, E., Knighton, P., Warner, J., Kar, P. S., Young, B., & Valabhji, J. (2022) · Diabetic Medicine · doi:10.1111/dme.14940 · Cited by 46 · see citing works
The Cardiometabolic Risk Profile of Young Adults With Diabetes in the U.S.
Saydah, S., Siegel, K. R., Imperatore, G., Mercado, C. I., & Gregg, E. W. (2019) · Diabetes Care · doi:10.2337/dc19-0707 · Cited by 48 · see citing works
“developing earlier complications caused by more rapid decline of b-cell function and development of complications (12).”
BackgroundJiménez‐Maldonado, A., García‐Suárez, P. C., Rentería, I., Moncada‐Jiménez, J., & Plaisance, E. P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165820 · Cited by 52 · see citing works
“Introduction Incidence of metabolic syndrome (MetS) and type 2 diabetes (T2D) in adults over age 18 continues to rise in developed and under-developed countries around the world [1,2].”
BackgroundDiabetes education in pediatrics: How to survive diabetes
Ergun-Longmire, B., Clemente, E. G., Maravolo, P. V., Roberts, C., Buth, K., & Greydanus, D. E. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101153 · Cited by 46 · see citing works
Hong, Y. H., Chung, I.-H., Han, K., Chung, S., & on Behalf of the Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0038 · Cited by 47 · see citing works
“Similar to older-onset T2DM, the major predisposing risk factors for T2DM in children are obesity, family history, and a sedentary lifestyle [3].”
BackgroundGlobal prevalence of prediabetes in children and adolescents: A systematic review and meta‐analysis
Han, C.-Y., Song, Q., Ren, Y.-C., Chen, X., Jiang, X.-S., & Hu, D. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13291 · Cited by 56 · see citing works
“It is not only highly prevalent in adults; the incidence of diabetes has also been increasing among young people.(2) In addition, the progress of diabetes in young participants could be faster and more disruptive than in participants with later onset of the disease, causing early morbidity and reduced quality of life.”
BackgroundNeovascularization Detection and Localization in Fundus Images Using Deep Learning
Tang, M. C. S., Teoh, S. S., Ibrahim, H., & Zunaina, E. (2021) · Sensors · doi:10.3390/s21165327 · Cited by 47 · see citing works
“Individuals are typically diagnosed with diabetes during their most prosperous years [2].”
BackgroundSargeant, J. A., Brady, E. M., Zaccardi, F., Tippins, F., Webb, D. R., Aroda, V. R., Gregg, E. W., Khunti, K. K., & Davies, M. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05174-9 · Cited by 47 · see citing works
Squillario, M., Bonaretti, C., Valle, A. L., Marco, E. D., Piccolo, G., Minuto, N., Patti, G., Napoli, F., Bassi, M., Maghnie, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36533-2 · Cited by 48 · see citing works
Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050
Huang, Q., Li, Y., Yu, M., Lv, Z.-D., Lu, F., Xu, N., Zhang, Q., Shen, J., Zhu, J., & Jiang, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1538143 · Cited by 46 · see citing works
Relation of Aortic Stiffness to Left Ventricular Remodeling in Younger Adults With Type 2 Diabetes
Gulsin, G. S., Swarbrick, D. J., Hunt, W., et al. (2018) · Diabetes · doi:10.2337/db18-0112 · Cited by 43 · see citing works
“Whereas type 2 diabetes was once a rarity in young people, increasingly the condition is diagnosed in children, adolescents, and adults under the age of 30 years (1).”
BackgroundTrends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013
Koye, D. N., Magliano, D. J., Reid, C. M., Pavkov, M. E., Chadban, S. J., McDonald, S. P., Polkinghorne, K. R., White, S., Paul, C. L., & Shaw, J. E. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.10.005 · Cited by 44 · see citing works
Jølle, A., Midthjell, K., Holmen, J., Carlsen, S. M., Tuomilehto, J. O., Bjørngaard, J. H., & Åsvold, B. O. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000769 · Cited by 47 · see citing works
“29 30 For instance, in the UK, the incidence of diabetes in people 40 years increased more than fivefold from 1991–1995 to 2006– 2010.”
BackgroundYoung-onset type 2 diabetes in South Korea: a review of the current status and unmet need
Yang, Y., Han, K., Sohn, T. S., & Kim, N. H. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.379 · Cited by 45 · see citing works
“This means that YOD have a more aggressive course of the disease than late-onset T2DM [1,3,18].”
BackgroundTian, Y., Qiu, Z., Wang, F., Deng, S., Wang, Y., Wang, Z., Yin, P., Huo, Y., Zhou, M., Liu, G., et al. (2024) · Diabetes Care · doi:10.2337/dca24-0012 · Cited by 43 · see citing works
Divakaran, S., Singh, A., Biery, D. W., Yang, J., DeFilippis, E. M., Collins, B., Ramsis, M., Qamar, A., Hainer, J. M., Klein, J., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0998 · Cited by 44 · see citing works
- Authors
- Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S.
- Affiliations
- Aston University (GB)
- Heart of England NHS Foundation Trust (GB)
- Corresponding author
- Bellary, Srikanth
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 6
- Issue
- 1
- Pages
- 69-80
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2748764116
- Cited by
- 824
- References
- 150
- Citations by year
- 2026: 73 · 2025: 118 · 2024: 112 · 2023: 118 · 2022: 134 · 2021: 107 · 2020: 99 · 2019: 44 · 2018: 17 · 2017: 2
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Aston Publications Explorer (Aston University) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, youth-onset type 2 diabetes, adolescents, young adults, obesity, family history (medicine), sedentary lifestyle, diabetes risk factors, diabetes complications, disease pathophysiology, diabetes management, quality of life
- MeSH terms
- Adolescent, Adult, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Male, Quality of Life, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-01.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-01.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review